News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Roche Holding AG (RHHBF.PK) Has Way to Get Antibody Therapies Into Brain; Discovery Opens "New Frontier"



5/26/2011 6:54:16 AM

Scientists at Roche Holding AG's (ROG.VX) biotechnology unit Genentech have found a way to get antibody-based therapies across a key barrier in the brain and deliver a payload of drugs that take aim at an elusive Alzheimer's target.

They said the findings from two studies, reported on Wednesday in the journal Science Translational Medicine, could open the door to new treatments for diseases like Alzheimer's, schizophrenia, Parkinson's and even autism.

Read at Bloomberg
Read at News Release
Read at Reuters


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES